InvestorsHub Logo
Post# of 253125
Next 10
Followers 839
Posts 120436
Boards Moderated 18
Alias Born 09/05/2002

Re: 10nisman post# 115994

Monday, 03/07/2011 2:13:35 PM

Monday, March 07, 2011 2:13:35 PM

Post# of 253125
Yes, I caught that brief segment on the webcast. As Wheeler said, MNTA is not running a safety-and-efficacy trial in support of its Copaxone ANDA, nor will it be required to do so as far as the company knows.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.